| Ytd | 29.18% | |
| 1y | 61.47% |
| Open | 134.95 | Prev Close | 135.84 | Low | 134.55 | High | 137.16 | Mkt Cap | 335.82B |
| Vol | 5.63M | Avg Vol | 10.20M | EPS | 3.21 | P/E | 42.36 | Forward P/E | 14.22 |
| Beta | 0.21 | Short Ratio | 3.22 | Inst. Own | 82.78% | Dividend | 3.40 | Div Yield | 2.50 |
| Ex Div Date | 09-15 | Earning | 08-04 | 50-d Avg | 125.48 | 200-d Avg | 113.81 | 1yr Est | 137.73 |
The bull market that started in 2022 still continues, making the market somewhat overvalued, and we
Dell Technologies (NYSE:DELL), JPMorgan Chase & Co. (NYSE:JPM) and Merck & Co. (NYSE:MRK) all touche
Merck (MRK) and GSK face regulatory and manufacturing hurdles to producing individual MMR vaccines,
MRK's Keytruda remains a key growth engine in 2026, but patent loss and rising competition could cha
NASHVILLE, Tenn.--(BUSINESS WIRE)--Sarah Cannon Research Institute (SCRI) announced a strategic coll
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
With all eyes locked on this morning's CPI release and the Strait of Hormuz nearly shut down, Wall S
President Donald Trump's latest executive order calls for splitting the measles, mumps and rubella,
Merck's strong Keytruda sales and pipeline progress support its long-term outlook, but falling estim
President Donald Trump signed an order Monday limiting core childhood vaccine recommendations to 11
https://youtu.be/H_RititNE8U
Positive readouts in cancer and cardiac drug trials could keep the rally going. Sizing up the stakes
Pfizer (NYSE:PFE | PFE Price Prediction) and Merck (NYSE:MRK) refreshed the dividend debate with the
The recommendations of Wall Street analysts are often relied on by investors when deciding whether t
In July 2026, the European Medicines Agency (EMA) accepted the application to expand marketing autho
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United S
Merck raised its 2026 sales outlook as pipeline gains, new launches and post-KEYTRUDA plans took foc
Merck (NYSE:MRK), known as MSD outside of the United States and Canada, announced that KEYTRUDA® (pe
Guggenheim analyst Vamil Divan maintains Merck & Co (NYSE:MRK) with a Buy and raises the pric
Merck & Co., Inc. NYSE: MRK reported second-quarter revenue of $16.6 billion, up 5% from a year earl
Total Revenue: $16.6 billion, an increase of 5% (4% excluding foreign exchange).KEYTRUDA Family Sale
Merck beat Q2 earnings and sales estimates as strong oncology and newer products lift results, promp
Merck cuts FY2026 adjusted EPS outlook nearly in half to $2.66-$2.76, citing $2.43/share in charges
Merck & Co., Inc. (MRK) Q2 2026 Earnings Call Transcript
Although the revenue and EPS for Merck (MRK) give a sense of how its business performed in the quart
Stock futures are building on the strong start to August, today buzzing on Strait of Hormuz buzz
Merck (MRK) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of
Merck & Co (NYSE:MRK) lowers FY2026 Adj EPS guidance from $5.04-$5.16 to $2.66-$2.76 vs $2.76 an
Merck & Co (NYSE:MRK) reported quarterly losses of $(0.13) per share which beat the analyst cons
Merck and Wellcome-backed Hilleman will manufacture Bundibugyo Ebola vaccine doses for clinical tria
Barclays analyst Emily Field maintains Merck & Co (NYSE:MRK) with a Overweight and raises the
Scott warns China’s new drug rules could threaten U.S. medicine security, urging America to reduce r
Initial access plans as part of Merck’s broader strategy include establishing early generic licensin
Trump says imported generic drugs face 0% tariffs for 2 years, before 100% and then 200% duties.
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Gilead & Merck Phase 3 data shows once-weekly ISL/LEN matches daily HIV meds in viral suppressio
For the tens of millions of Americans who cannot push their LDL cholesterol (trivially known as "
HC Wainwright lifted Arcus Biosciences' price target, citing broader revenue potential for casda
Scott urges Trump admin to increase tariffs on Chinese generic drug makers, citing forced labor &
Wall St analysts changed outlook on top names. KBW cut AON PT to $400, Barclay's cut T PT to $24
US lawmakers probe Merck and AbbVie over national security and ethical risks tied to clinical trials
Here's a look at this week's earnings calendar, featuring over 100 S&P 500 members.